Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation

Intravenous immunoglobulin (IVIG) is used as an immunomodulatory agent in the treatment of various autoimmune/inflammatory diseases although its mechanism of action remains elusive. Recently, nonfucosylated IgG has been shown to be preferentially bound to Fcγ receptor IIIa (FcγRIIIa) on circulating...

Descripción completa

Detalles Bibliográficos
Autores principales: Mimura, Yusuke, Mimura-Kimura, Yuka, Saldova, Radka, Rudd, Pauline M., Jefferis, Roy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831331/
https://www.ncbi.nlm.nih.gov/pubmed/35154135
http://dx.doi.org/10.3389/fimmu.2022.818382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831331/
https://www.ncbi.nlm.nih.gov/pubmed/35154135
http://dx.doi.org/10.3389/fimmu.2022.818382

Ejemplares similares